Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation
Huanling Guo, Jinsheng Huang, Tan Yang, et al.
Nano Today (2022) Vol. 43, pp. 101425-101425
Closed Access | Times Cited: 23

Showing 23 citing articles:

A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
Xuan Wang, Yingqi Liu, Chencheng Xue, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 140
An Oral Nanomedicine Elicits In Situ Vaccination Effect against Colorectal Cancer
Menghang Zu, Ya Ma, Jun Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3651-3668
Open Access | Times Cited: 15
Radiofrequency-Activated Pyroptosis of Bi-Valent Gold Nanocluster for Cancer Immunotherapy
Qingqing Zhang, Dingwen Shi, Mengqin Guo, et al.
ACS Nano (2022) Vol. 17, Iss. 1, pp. 515-529
Closed Access | Times Cited: 38
Nano-enabled colorectal cancer therapy
Qingqing Pan, Fan Xi, Li Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 548-564
Closed Access | Times Cited: 32
Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy
Qingbin He, Runxiao Zheng, Junchi Ma, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 23
Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer
Yiyao Wang, Hanqi Lei, Binyuan Yan, et al.
Acta Biomaterialia (2023) Vol. 168, pp. 593-605
Open Access | Times Cited: 22
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 22
Ca & Mn dual-ion hybrid nanostimulator boosting anti-tumor immunity via ferroptosis and innate immunity awakening
Xi Deng, Tianzhi Liu, Yutong Zhu, et al.
Bioactive Materials (2023) Vol. 33, pp. 483-496
Open Access | Times Cited: 19
Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
Ning Liu, Renshuai Zhang, Qiang Shi, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106550-106550
Closed Access | Times Cited: 18
Nanodrug Delivery Systems in Antitumor Immunotherapy
Zishuo Guo, Jinhong Ye, Xuehao Cheng, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 7
Immunostimulatory effects of thermal ablation: Challenges and future prospects
Peng Liu, Zhigang Wei, Xin Ye
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 531-539
Open Access | Times Cited: 4
Nomadic Nanomedicines: Medicines Enabled by the Paracrine Transfer Effect
Krishna Paranandi, Eliz Amar‐Lewis, Chad A. Mirkin, et al.
ACS Nano (2025)
Closed Access
Harnessing Pd-1-Overexpressing Macrophage Membrane for Preparation of Lenvatinib-Loaded Vesicles to Boost Immunotherapy Against Hcc Recurrence after Radiofrequency Ablation
Hui Guo, Guangliang Huang, Haiyi Long, et al.
(2025)
Closed Access
Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics
Yingnan Shen, Hogyeong Gwak, Bumsoo Han
The Analyst (2023) Vol. 149, Iss. 3, pp. 614-637
Closed Access | Times Cited: 9
Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy
Zhiliang Gao, Ning Wang, Yuan Ma, et al.
Nano Today (2023) Vol. 54, pp. 102096-102096
Closed Access | Times Cited: 9
A Self‐Delivery Nanodrug Simultaneously Inhibits COX‐2/PGE2 Mediated Inflammation and Downregulates PD‐L1 to Boost Photoimmunotherapy
Jinmei Lai, Peiling Chen, Qun‐Ying Shi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 3
Size‐Tunable Nanoregulator‐Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma
Yuhao Tang, Zhilin Shu, Meiyan Zhu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Closed Access | Times Cited: 8
Boosting Checkpoint Immunotherapy with Biomimetic Nanodrug Delivery Systems
Wenjing Chen, Chenlu Tang, Guijin Chen, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 14
Closed Access | Times Cited: 2
Nanomaterials Enhance Pyroptosis-Based Tumor Immunotherapy
Fujian Ji, Chunyu Shi, Zhenbo Shu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5545-5579
Open Access | Times Cited: 2
Surface Membrane Coating as a Versatile Platform for Modifying Antitumor Nanoparticles
Qìng Yu, Wenzhe Wang, Haixia Ji, et al.
ACS Materials Letters (2022) Vol. 4, Iss. 10, pp. 2019-2050
Closed Access | Times Cited: 11
Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system
Yifan Miao, Jinrui Liu, Hongying Xiao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107902-107902
Closed Access | Times Cited: 1
Application of nanomaterials in combined thermal ablation and immunotherapy for liver tumors
Huanling Guo, Xiao-Yan Xie, Ming Xu
Shijie huaren xiaohua zazhi (2022) Vol. 30, Iss. 19, pp. 829-837
Open Access | Times Cited: 2
Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy
Qingbin He, Runxiao Zheng, Junchi Ma, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top